期刊文献+

普罗帕酮与奎尼丁及其合用抗实验性心律失常作用

Antiarrhythmic Effect of Propafenone and Quinidine Combination in Rabbits
在线阅读 下载PDF
导出
摘要 目的:研究普罗帕酮与奎尼丁对实验动物心律失常的作用。方法:从药效动力学和药代动力学两方面考察小剂量普罗帕酮(Pro)和奎尼丁(Qui)合用,对抗肾上腺素(EP)所致家兔心律失常的作用。结果:Pro(3mg/kg)和Qui(6mg/kg)静脉注射全量合用及半量合用,可明显推迟室性心律失常(VA)和室速(VT)的发作,缩短持续时间,并减少两者的发生率。结论:半量Pro和Qui联合用药后抗心律失常作用明显增强,采用高效液相色谱法测定Qui与Pro的血药浓度,药物动力学参数均无显著影响。 Objective:To study the antiarrhythmic effects of propafenone (Pro) and quinidine (Qui) on arrhythmias in rabbits. Methods: To observe the effect of small dose of Pro and Qui on adrenaline-induced arrhythmias in rabbits by pharmacodynamics and pharmacokinetics. Results: With a combination of Pro (3 mg·kg^-1·iv) and Qui (6 mg·kg^-1·iv) and with a combination two at half dose prominently prolonged the onset of ventricular arrhythmias (VA) and ventricular tachyarrhythmias (VT) and reduced the duration and the incidence of VA and VT. Conclusion: The effects of combination Pro with Qui in half dose were markedly increased on antiarrhythmias. The study showed Qui has no influence on the metabolism and pharmacokinetic parameters of Pro in rabbits.
出处 《天津医药》 CAS 北大核心 2006年第2期111-113,共3页 Tianjin Medical Journal
关键词 普罗帕酮 奎尼丁 心律失常 Propafenone Quinidine arrhythmia rabbits
  • 相关文献

参考文献6

二级参考文献23

  • 1李东升,张才丽.高效液相色谱法同时测定兔血清中普罗帕酮和奎尼丁的浓度[J].天津医科大学学报,2004,10(2):238-239. 被引量:5
  • 2Serodio P, Vega-Saenz DM, Rudy B. Cloning of a novel component of a-type K+ channels operating at subthreshold potentials with unique expression in heart and brain. J Neurophysiol.1996;75(5) :2174-9.
  • 3Franqueza L, Valenzuela C, Eck J et al. Functional expression of an inactivating potassium channel (Kv4.3) in a mammalian cell line. Cardiovasc Res, 1999;41(1):212-9.
  • 4Wickenden AD, Jegla TJ, Kaprielian R, Backx PH. Regional contributions of Kvl. 4, Kv4.2, and Kv4.3 to transient outward K+ current in rat ventricle. Am J Physiol, 1999;276(5 Pt 2):H1599-607.
  • 5Rolf S, Haverkamp W, Borggrefe M et al. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in xenopus oocytes. Naunyn Schmiedebergs Arch Pharmacol. 2000 ;362(1) : 22 - 31.
  • 6Seki A, Hagiwara N, Kasanuki H. Effects of propafenone on K currents in human atrial myocytes. Br J Pharmacol, 1999;126(5) :1153-62.
  • 7Ahring PK, Strobaek D, Christophersen P. Stable expression of the human large-conductance Ca2+ -activated K+ channel alpha-and beta-subunits in HEK293 cells. FEBS Lett, 1997;415(1):67-70.
  • 8Duan D, Fermini B, Nattel S. Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J Pharmacol Exp Ther, 1993;264(3) :1113-23.
  • 9Slawsky MT, Castle NA. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes, J Pharmacol Exp Ther, 1994;269(1) :66-74.
  • 10Ohya S, Tanaka M, Oku T et al. Molecular cloning and tissue distribution of an alternatively spliced variant of an a-type K+ channel alpha-subunit, Kv4.3 in the Rat. FEBS Lett, 1997,420(1) :47-53.

共引文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部